BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic

[Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai Management anticipates $9 million in 2010 revenues from this initiative XIANYANG, China, December 29, 2009 (Xinhua-PRNewswire-FirstCall) Management anticipates approximately $9 million in incremental revenues during 2010 from these two new markets with average gross margins of approximately 72%. Biostar launched its marketing and operational initiatives for]

By | 2016-03-03T15:04:00+00:00 December 30th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, to Launch Xin Aoxing Oleanolic Acidpsules in Beijing and Shanghai Management anticipates $9 million in 2010 revenues from this initiative XIANYANG, China, December 29, 2009 (Xinhua-PRNewswire-FirstCall) Management anticipates approximately $9 million inremental revenues during 2010 from these two new markets with average gross margins of approximately 72%. Biostar launched its marketing and operational]

By | 2016-02-07T17:47:38+00:00 December 30th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, to Launch Xin Aoxing Oleanolic Acidpsules

[Biostar Pharmaceuticals, to Launch Xin Aoxing Oleanolic Acidpsules in Beijing and Shanghai Management anticipates $9 million in 2010 revenues from this initiative XIANYANG, China, December 29, 2009 (Xinhua-PRNewswire-FirstCall) Management anticipates approximately $9 million inremental revenues during 2010 from these two new markets with average gross margins of approximately 72%. Biostar launched its marketing and operational]

By | 2016-02-07T17:48:33+00:00 December 30th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] SC 13D/A: (Original Filing)

[1 Name of Reporting Person Andrew Barron Worden I.R.S. Identification No. of Above Person 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds PF Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Number of 7 Sole Voting Power Shares Owned]

By | 2016-03-03T15:07:23+00:00 December 29th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] SC 13D/A: 1 Name of Reporting Person Andrew Barron Worden

[1 Name of Reporting Person Andrew Barron Worden I.R.S. Identification No. of Above Person 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds PF Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Number of 7 Sole Voting Power Shares Owned]

By | 2016-03-03T15:08:57+00:00 December 29th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] SC 13D/A: (Original Filing)

[SCHEDULE 13D/A (Amendment No 2) Biostar Pharmaceuticals, (Name of Issuer)mmon Stock (Title of Class of Securities) 090678103 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) December 16, 2009 (Date of Event which Requires Filing of this Statement) If]

By | 2016-02-07T17:49:29+00:00 December 29th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] SC 13D/A: SCHEDULE 13D/A (Amendment No 2) Biostar Pharmaceuticals, (Name

[SCHEDULE 13D/A (Amendment No 2) Biostar Pharmaceuticals, (Name of Issuer)mmon Stock (Title of Class of Securities) 090678103 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) December 16, 2009 (Date of Event which Requires Filing of this Statement) If]

By | 2016-02-07T17:50:27+00:00 December 29th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Secures Letter of Intent to Acquire Xi’an-Based Medical Equipment and Nutrients Manufacturer Potential acquisition will expand product portfolio and Introduces Medical Devices to BioStar’s Distribution Network XIANYANG, China, December 16, 2009 (Xinhua-PRNewswire-FirstCall) BSPM News The Acquiree manufactures and distributes topical hernia treatment belts with two traditional Chinese medicine bags being applied to body points associated with hernia.]

By | 2016-03-03T15:11:39+00:00 December 16th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Secures Letter of Intent to

[Biostar Pharmaceuticals, Inc. Secures Letter of Intent to Acquire Xi’an-Based Medical Equipment and Nutrients Manufacturer Potential acquisition will expand product portfolio and Introduces Medical Devices to BioStar’s Distribution Network XIANYANG, China, December 16, 2009 (Xinhua-PRNewswire-FirstCall) BSPM News The Acquiree manufactures and distributes topical hernia treatment belts with two traditional Chinese medicine bags being applied to body points associated with hernia.]

By | 2016-03-03T15:12:56+00:00 December 16th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Secures Letter of Intent to Acquire Xian-Based Medical Equipment and Nutrients Manufacturer Potential acquisition will expand product portfolio and Introduces Medical Devices to BioStars Distribution Network XIANYANG, China,December 16, 2009 (Xinhua-PRNewswire-FirstCall) BSPM News The Acquiree manufactures and distributes topical hernia treatment belts with two traditional Chinese medicine bags being applied to body pointssociated]

By | 2016-02-07T17:51:27+00:00 December 16th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar